<https://www.pharmaceutical-technology.com/analyst-comment/out-of-spec-cell-therapy-manufacturing-an-ethical-dilemma-for-cdmos-and-doctors/>
<http://schema.org/description>
"Autologous cell therapy production presents an unusually difficult conflict for manufacturers and doctors, who want to get the product to the patient in time and yet need it to meet quality standards."
<https://www.pharmaceutical-technology.com/analyst-comment/out-of-spec-cell-therapy-manufacturing-an-ethical-dilemma-for-cdmos-and-doctors/>